Box score
Lonestar Medicines, Inc.
Reported $25M sold in a new Form D filed February 23, 2026 (Boston, Massachusetts).
- Biggest raise
- $25M filed Feb 23, 2026
- League
- Bio & Health Biotechnology
- Based in
- Boston, Massachusetts
- Season rank
- #107 of 1,121 in the Bio & Health League; #877 of 10,745 overall (2026)
- Incorporated
- 2025
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-02-23 | New notice | $25M | $45M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2111460.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Dash Bio, Inc. | Bio & Health | $30M |
| 2 | Cue Biopharma, Inc. | Bio & Health | $30M |
| 3 | Apnimed, Inc. | Bio & Health | $25M |
| 4 | Nocion Therapeutics, Inc. | Bio & Health | $23M |
| 5 | Pacegenix, Inc. rookie | Bio & Health | $22.5M |
| 6 | Lifeward Ltd. | Bio & Health | $20M |